Molecular mechanisms of viral oncogenesis in humans

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Reviews Microbiology

• Publication date

  2018-08-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41579-018-0064-6PMID 30143749PMCID PMC6336458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour viruses and innate immunity

  2017cited by this paper
• Modulation of Wnt signaling pathway by hepatitis B virus

  2017cited by this paper
• Epstein-Barr Virus LMP1-Mediated Oncogenicity

  2017cited by this paper
• High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway

  2017cited by this paper
• Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis

  2017cited by this paper
• Wnt/ b -Catenin Signaling, Disease, and Emerging Therapeutic Modalities

  2017cited by this paper
• 40 Years on

  2017cited by this paper
• Modulation of oncogenic signaling networks by Kaposi’s sarcoma-associated herpesvirus

  2017cited by this paper
• HPV vaccines - A review of the first decade.

  2017cited by this paper
• Cytoplasmic chromatin triggers inflammation in senescence and cancer

  2017cited by this paper
• 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

  2017cited by this paper
• cGAS surveillance of micronuclei links genome instability to innate immunity

  2017cited by this paper
• Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing

  2016cited by this paper
• The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary

  2016cited by this paper
• Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

  2016cited by this paper
• Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis

  2016cited by this paper
• Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation

  2016cited by this paper
• The Role of Gammaherpesviruses in Cancer Pathogenesis

  2016cited by this paper
• Metabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization

  2016cited by this paper
• Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.

  2016cited by this paper
• HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)

  2016cited by this paper
• Mechanisms of HBV-induced hepatocellular carcinoma.

  2016cited by this paper
• Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor

  2016cited by this paper
• PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

  2016cited by this paper
• Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.

  2016cited by this paper
• Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS

  2016cited by this paper
• Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis.

  2016cited by this paper
• Merkel cell polyomavirus infection and Merkel cell carcinoma.

  2016cited by this paper
• Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection.

  2016cited by this paper
• Carcinogenic human papillomavirus infection

  2016cited by this paper
• Compromised MAPK signaling in human diseases: an update

  2015cited by this paper
• The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses

  2015cited by this paper
• Hepatitis C virus-induced hepatocellular carcinoma

  2015cited by this paper
• Sofosbuvir, a Significant Paradigm Change in HCV Treatment

  2015cited by this paper
• Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

  2015cited by this paper
• DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway

  2015cited by this paper
• Evasion of affinity-based selection in germinal centers by Epstein–Barr virus LMP2A

  2015cited by this paper
• How do persistent infections with hepatitis C virus cause liver cancer?

  2015cited by this paper
• EBV Persistence--Introducing the Virus.

  2015cited by this paper
• Large T and small T antigens of Merkel cell polyomavirus.

  2015cited by this paper
• HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model".

  2015cited by this paper
• Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses

  2015cited by this paper
• The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets

  2015cited by this paper
• Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein.

  2015cited by this paper
• Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells

  2015cited by this paper
• KSHV Reactivation and Novel Implications of Protein Isomerization on Lytic Switch Control

  2015cited by this paper
• Hepatitis C virus RNA functionally sequesters miR-122.

  2015cited by this paper
• Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1

  2015cited by this paper
• What's the damage? The impact of pathogens on pathways that maintain host genome integrity.

  2014cited by this paper
• Regulation of HTLV-1 Tax Stability, Cellular Trafficking and NF-κB Activation by the Ubiquitin-Proteasome Pathway

  2014cited by this paper
• Human Viruses and Cancer

  2014cited by this paper
• Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook

  2014cited by this paper
• The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease

  2014cited by this paper
• Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.

  2014cited by this paper
• an update on

  2014cited by this paper
• Host DNA Damage Response Factors Localize to Merkel Cell Polyomavirus DNA Replication Sites To Support Efficient Viral DNA Replication

  2014cited by this paper
• Targeting PI3K/Akt/mTOR Signaling in Cancer

  2014cited by this paper
• HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.

  2014cited by this paper
• Hepatitis B Virus Polymerase Disrupts K63-Linked Ubiquitination of STING To Block Innate Cytosolic DNA-Sensing Pathways

  2014cited by this paper
• Cancer "causation" by infections--individual contributions and synergistic networks.

  2014cited by this paper
• Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook

  2014cited by this paper
• Counteracting Effects of Cellular Notch and Epstein-Barr Virus EBNA2: Implications for Stromal Effects on Virus-Host Interactions

  2014cited by this paper
• HTLV-1 Tax-Mediated Inhibition of FOXO3a Activity Is Critical for the Persistence of Terminally Differentiated CD4+ T Cells

  2014cited by this paper
• Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity

  2013cited by this paper
• HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells

  2013cited by this paper
• A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks vFLIP K13-Induced NF-κB

  2013cited by this paper
• The Human Papillomavirus Type 8 E6 Protein Interferes with NOTCH Activation during Keratinocyte Differentiation

  2013cited by this paper
• The long and short of microRNA.

  2013cited by this paper
• ATM and ATR Activities Maintain Replication Fork Integrity during SV40 Chromatin Replication

  2013cited by this paper
• Merkel Cell Polyomavirus Large T Antigen Disrupts Host Genomic Integrity and Inhibits Cellular Proliferation

  2013cited by this paper
• A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

  2013cited by this paper
• Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins - eScholarship

  2012cited by this paper
• MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles

  2012cited by this paper
• Epidemiological Aspects and World Distribution of HTLV-1 Infection

  2012cited by this paper
• Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation

  2012cited by this paper
• Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store

  2012cited by this paper
• Infection of Epstein–Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression

  2012cited by this paper
• Interpreting cancer genomes using systematic host perturbations by tumour virus proteins

  2012cited by this paper
• Cellular Entry of Human Papillomavirus Type 16 Involves Activation of the Phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and Inhibition of Autophagy

  2012cited by this paper
• Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.

  2012cited by this paper
• Human Papillomaviruses Recruit Cellular DNA Repair and Homologous Recombination Factors to Viral Replication Centers

  2012cited by this paper
• The microcosmos of cancer

  2012cited by this paper
• Novel mechanisms of EBV-induced oncogenesis.

  2012cited by this paper
• The double-edged sword of Notch signaling in cancer.

  2012cited by this paper
• Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling

  2012cited by this paper
• Treatment of a Human Papillomavirus Type 31b-Positive Cell Line with Benzo[a]Pyrene Increases Viral Titer through Activation of the Erk1/2 Signaling Pathway

  2011cited by this paper
• Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: A role for HBV-induced HCC

  2011cited by this paper
• Nuclear Accumulation of the Papillomavirus E1 Helicase Blocks S-Phase Progression and Triggers an ATM-Dependent DNA Damage Response

  2011cited by this paper
• Discovery of a Viral NLR Homolog that Inhibits the Inflammasome

  2011cited by this paper
• Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.

  2011cited by this paper
• KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.

  2011cited by this paper
• The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?

  2011cited by this paper
• Notch signalling in solid tumours: a little bit of everything but not all the time

  2011cited by this paper
• Cutaneous Papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling

  2011cited by this paper
• Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.

  2011cited by this paper
• The Papillomavirus E1 Helicase Activates a Cellular DNA Damage Response in Viral Replication Foci

  2011cited by this paper
• Why do viruses cause cancer? Highlights of the first century of human tumour virology

  2010cited by this paper
• Genomes in conflict: maintaining genome integrity during virus infection.

  2010cited by this paper
• An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells

  2010cited by this paper
• Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission

  2010cited by this paper

• Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV.

  2026cites this paper
• Viruses and the host replisome: discovering oncogenic mechanisms of small DNA tumor viruses

  2026cites this paper
• A Deep Dive Into Oncogenic Viruses Understanding Their Role in Cancer and Approaches for Prevention.

  2026cites this paper
• Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy.

  2026cites this paper
• Oncogenic viruses rewire the epigenome in human cancer

  2025cites this paper
• Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies

  2025cites this paper
• A skin organoid-based infection platform identifies an inhibitor specific for HFMD

  2025cites this paper
• Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy.

  2025cites this paper
• Comprehensive resolution and classification of the Epstein Barr virus transcriptome

  2025cites this paper
• Research progress of DNA methylation in the screening of cervical cancer and precancerous lesions

  2025cites this paper
• Cytoskeletal Remodeling by Oncoviruses: A Key Factor in Tumor Invasion and Metastasisa

  2025cites this paper
• HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development

  2025cites this paper
• The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies

  2025cites this paper
• Structure-Activity-Relationship Exploration and Animal Validation of a Novel Assembly Modulator Small Molecule Chemical Series with Pan-Cancer Selective Cytotoxicity

  2025influential citation
• Viruses in gastrointestinal cancers: Molecular pathogenesis, oncogenic mechanisms, and translational perspectives.

  2025cites this paper
• Interlocking host and viral cis-regulatory networks drive Merkel cell carcinoma

  2025cites this paper
• Viral oncogenesis in cancer: from mechanisms to therapeutics

  2025cites this paper
• Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential

  2025cites this paper
• The COVID-19 pandemic increased the incidence of newly diagnosed cancers: evidence from a large cohort study in Southern Italy

  2025cites this paper
• The Impact of Oncogenic Viruses on Cancer Development: A Narrative Review

  2025cites this paper
• Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches

  2025cites this paper
• The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses

  2025influential citation
• Oncogenic Viruses in Organ Transplantation: Implications of Virus-Host Interactions for Cancer Development

  2025cites this paper
• Genetic and molecular profiling in Merkel Cell Carcinoma: Focus on MCPyV oncoproteins and emerging diagnostic techniques.

  2025cites this paper
• Evolutionary interplay between viruses and R‐loops

  2025cites this paper
• Recent advances in infections as risk factors for lymphoma: a review of the effects of viral, bacterial, and fungal infections in lymphoma

  2025influential citation
• Defective but tumorigenic: the evolutionary and functional roles of mutated oncoviruses

  2025influential citation
• From lab to life: technological innovations in transforming cancer metastasis detection and therapy

  2025cites this paper
• Photoactivated nanovaccines.

  2025cites this paper
• Convergent Mechanisms in Virus-Induced Cancers: A Perspective on Classical Viruses, SARS-CoV-2, and AI-Driven Solutions

  2025cites this paper
• Phosphoinositide dynamics in virus-associated malignancies.

  2025cites this paper
• Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects

  2025cites this paper
• Virus Protein-Specific Immune Responses in Selective Depletion of Lymphocyte Populations Using Monoclonal Antibodies in Bolivian Squirrel Monkeys (Saimiri boliviensis boliviensisv)

  2025cites this paper
• The double-edged sword: How SARS-CoV-2 might fuel lung cancer: Investigating the potential oncogenic mechanisms of the novel coronavirus in lung carcinogenesis.

  2025cites this paper
• The interplay between tissue‐resident microbiome and host proteins by integrated multi‐omics during progression of colorectal adenoma to carcinoma

  2025cites this paper
• Virological perspectives of the current situation of oncogenic viruses in Egypt: a review

  2025cites this paper
• Systematic Discovery of Pathogen Effector Functions across Human Pathogens and Pathways

  2025cites this paper
• Oncolytic virus and immunogenic cell death in cancer therapy

  2025influential citation
• IGFBP2 up-regulation by EBV via TGF-β signaling: a key mechanism in nasopharyngeal carcinoma progression

  2025cites this paper
• Chronic Viral Infections and Development of Vascular Malformations/Tumors of Head and Neck: Is There a Correlation?

  2025cites this paper
• A Landscape of Cancer Initiation and Cancer Stem Cells

  2025cites this paper
• Targeting Intratumoral Bacteria for Cancer Treatment.

  2025cites this paper
• High Proportion of Cytomegalovirus DNA from Tissue Samples of Non Small Cell Lung Carcinoma in Persahabatan Hospital National Respiratory Center, Indonesia

  2025cites this paper
• Acetylation in Viral Infection and Disease.

  2025cites this paper
• Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients Associated With Major Human Oncoviruses

  2025cites this paper
• A Review of Mitochondrial Involvement in Cell Death Pathways Induced by Oncogenic Viruses

  2025cites this paper
• Challenges and Opportunities in Analyzing Cancer-Associated Microbiomes.

  2025cites this paper
• Harnessing viral footprints in circulating free DNA (cfDNA) for early cancer detection: A focus on liquid‐biopsy‐based screening

  2025cites this paper
• Leveraging T cells for cancer immunotherapy

  2025cites this paper
• Immunogenetics of longevity and its association with human endogenous retrovirus K

  2025cites this paper
• UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma

  2025cites this paper
• Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer’s defenses

  2025cites this paper
• The Subtle Threat of Human Papilloma Virus: A Comprehensive Overview

  2025cites this paper
• FOXA1 Transcriptional Repression of PLSCR1 Inhibits Tongue Squamous Cell Carcinoma Progression

  2025cites this paper
• RNA cargo in motion: the exosomal connection to head and neck cancers

  2025cites this paper
• A medicinal chemistry overview of direct-acting antivirals approved in 2013-2024 by US FDA.

  2025cites this paper
• Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers.

  2025cites this paper
• The role and diagnostic value of deregulated miRNAs in cervical cancer

  2025cites this paper
• Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies

  2025cites this paper
• Quality assessment strategy development and analytical method selection of GMP grade biological drugs for gene and cell therapy

  2025cites this paper
• Роль некоторых вирусов в развитии колоректального рака

  2025cites this paper
• Editorial: Cancer in people living with HIV/AIDS

  2025cites this paper
• Human papillomavirus infection and vaccination with thyroid diseases: mechanistic links and immunological insights

  2025cites this paper
• Cancer Nanovaccines: Nanomaterials and Clinical Perspectives.

  2024cites this paper
• A review: cellular attachment and entry factors of human tumor-associated viruses

  2024cites this paper
• The footprint of gut microbiota in gallbladder cancer: a mechanistic review

  2024influential citation
• Viruses in glioblastoma: an update on evidence and clinical trials

  2024cites this paper
• Navigating therapeutic strategies: HPV classification in head and neck cancer

  2024cites this paper
• An Overview of the Unfolded Protein Response (UPR) and Autophagy Pathways in Human Viral Oncogenesis.

  2024cites this paper
• Toward a Unified Theory of Why Young People Develop Cancer.

  2024cites this paper
• STINGing Defenses: Unmasking the Mechanisms of DNA Oncovirus-Mediated Immune Escape

  2024cites this paper
• The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses

  2024cites this paper
• Prognostic and Therapeutic Potential of STAT3: Opportunities and Challenges in Targeting HPV-Mediated Cervical Carcinogenesis.

  2024cites this paper
• Abortive Infection of Animal Cells: What Goes Wrong.

  2024cites this paper
• Roles of reactive oxygen species in inflammation and cancer

  2024cites this paper
• Computational identification and experimental verification of a novel signature based on SARS-CoV-2–related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients

  2024cites this paper
• High‐risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects

  2024cites this paper
• Abnormal protein SUMOylation in liver disease: novel target for therapy

  2024cites this paper
• The role and impact of viruses on cancer development.

  2024cites this paper
• PTEN regulation in virus-associated cancers.

  2024cites this paper
• DNA damage-inducing endogenous and exogenous factors and research progress

  2024cites this paper
• Small molecule protein assembly modulators with pan-cancer therapeutic efficacy

  2024cites this paper
• Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence

  2024cites this paper
• The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53

  2024cites this paper
• Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis

  2024cites this paper
• Prediction of viral oncoproteins through the combination of generative adversarial networks and machine learning techniques

  2024cites this paper
• Clinical implications of cytomegalovirus in glioblastoma progression and therapy

  2024cites this paper
• Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis

  2024cites this paper
• SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization

  2024cites this paper
• Tumor Initiation and Progression in People Living on Antiretroviral Therapies

  2024cites this paper
• Dual Roles of Host Zinc Finger Proteins in Viral RNA Regulation: Decay or Stabilization

  2024cites this paper
• EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus’ Resemblance to Oncoviruses

  2024cites this paper
• Chronic Viral Infections and Cancer, Openings for Therapies and Vaccines

  2024cites this paper
• HCMV detection in Asian gastric cancer RNA-seq data sets and clinical validation in Indian GC patients reveals the HCMV-GC specific gene signatures

  2024cites this paper
• In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells

  2024cites this paper
• Applications of cell therapy in the treatment of virus-associated cancers

  2024cites this paper
• Navigating the landscape of HPV-associated cancers: From epidemiology to prevention.

  2024cites this paper
• Intra-host genomic diversity and integration landscape of human tissue-resident DNA virome

  2024cites this paper
• The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses

  2024cites this paper
• Hybrid-Capture Target Enrichment in Human Pathogens: Identification, Evolution, Biosurveillance, and Genomic Epidemiology

  2024cites this paper